Despite the presence of HIV-1 in the oral cavity, transmission of the virus through saliva is rare, which implicates innate/natural antiviral mechanisms for suppressing transmission. Such endogenous antiviral molecules, including secretory leukocyte protease inhibitor (SLPI) and thrombospondin (TSP-1) inhibit HIV-1 infection of mononuclear cells during or soon after internalization. To further clarify the antiviral functions of SLPI as well as its role in innate host defense, a multifaceted approach has revealed that in addition to antiproteolytic activity, SLPI inhibits the transcription factor NF-kappa B to block monocyte/macrophage cytokine and chemokine synthesis. Generation of mice homozygous for a null mutation of SLPI have provided insight into its patterns of expression, function and regulation. In additional studies focusing on the regulation of HIV production after infection, opportunistic pathogens and immune activation were shown to influence viral replication. For example, Mycobacterium avium promotes HIV infection by activating the NF-kappa B pathway to stimulate cytokine and chemokine production and HIV co-receptor (CCR5) expression, while inhibiting apoptosis. This results in accumulation of susceptible viral host cells which favors viral replication. In tonsils and in sites of mucosal inflammation, the dynamic relationship between lymphocytes, macrophages and high levels of HIV emphasizes that immune activation contributes to viral progression and suggests interventional approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000513-10
Application #
6289680
Study Section
Special Emphasis Panel (OIIB)
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Institute of Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Greenwell-Wild, Teresa; Vazquez, Nancy; Jin, Wenwen et al. (2009) Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 114:1864-74
Mavragani, Clio P; Niewold, Timothy B; Moutsopoulos, Niki M et al. (2007) Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 56:3995-4004
Peng, Gang; Greenwell-Wild, Teresa; Nares, Salvador et al. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110:393-400
Moutsopoulos, Niki M; Nares, Salvador; Nikitakis, Nikolaos et al. (2007) Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission. Am J Pathol 171:571-9
Peng, Gang; Lei, Ke Jian; Jin, Wenwen et al. (2006) Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203:41-6
Moutsopoulos, N M; Greenwell-Wild, T; Wahl, S M (2006) Differential mucosal susceptibility in HIV-1 transmission and infection. Adv Dent Res 19:52-6
Vazquez, Nancy; Greenwell-Wild, Teresa; Rekka, Sofia et al. (2006) Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages. J Leukoc Biol 80:1136-44
Wahl, Sharon M; Greenwell-Wild, Teresa; Vazquez, Nancy (2006) HIV accomplices and adversaries in macrophage infection. J Leukoc Biol 80:973-83
Riley, E M; Wahl, S; Perkins, D J et al. (2006) Regulating immunity to malaria. Parasite Immunol 28:35-49
Moutsopoulos, Niki M; Vazquez, Nancy; Greenwell-Wild, Teresa et al. (2006) Regulation of the tonsil cytokine milieu favors HIV susceptibility. J Leukoc Biol 80:1145-55

Showing the most recent 10 out of 21 publications